Intensive BP lowering effective at CV risk reduction in patients with history of cancer

Intensive BP lowering may be safe in patients with a history of cancer not currently receiving treatment, according to a post hoc analysis of the SPRINT trial published in Hypertension.
“Hypertension, the most common comorbidity among patients with cancer, is a major contributor to the increased risk of adverse cardiovascular events. In the United States, a national health survey study identified hypertension in around 53% of > 13,000 cancer survivors,” Wenjie Li, of the department of cardiology at Anzhen Hospital in Beijing, and colleagues wrote. “Management of

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart